Sponsor

Pikralida Sp. z o.o.

Poland Ul. Uniwersytetu Poznanskiego 10, 61-614 Poznan, Poland

About the sponsor

Research activity is centered on pharmacokinetic evaluation in healthy subjects, with interest in how an orally administered compound is handled by the body over time.

Oral drug absorption
Single-dose exposure
Multiple-dose exposure

The sponsor’s clinical interest is focused on early human assessment of PKL-021 in a controlled volunteer setting.

About Specializations

Pikralida Sp. z o.o. runs clinical trials in conditions such as Post-traumatic epilepsy, Post stroke epilepsy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Post-traumatic epilepsy+1

Not recruiting

Registered drugNo placebo

Pharmacokinetic Study of Oral Marimastat (PKL-021) and Heparin Sodium in Healthy Adult Subjects

Registered drugNo placebo

Czechia

Participants:18–64 years · Healthy volunteers
Substances:Heparin Sodium
Sponsor:Pikralida Sp. z o.o.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →